Delivery Order SPE2DB20D3303-SPE2DB26FY2L7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $21,268.37 to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in syringe form (0.5mL). This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The contract was awarded on November 4, 2025, with an ultimate completion date of November 5, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $24,506.55 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5mL) on July 24, 2025, with an ultimate completion date of July 25, 2025. This delivery order represents a competitive, firm fixed-price award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used for immunization against pneumococcal disease,...
- The Defense Logistics Agency awarded a $3,267.56 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in syringe form (0.5mL units) on September 13, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease and represents a...
- The Defense Logistics Agency awarded a delivery order valued at $21,884.70 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5 mL) on July 17, 2025, with an ultimate completion date of July 18, 2025. This firm fixed price delivery order represents a non-set-aside competitive award and is being performed at the contractor's facility in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal vaccine used to prevent pneumococcal disease in eligible populations, making this order part of...
- The Defense Logistics Agency awarded a delivery order valued at $16,390.61 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 vaccine in 0.5ML syringes. This firm fixed-price, non-set-aside contract was awarded on June 2, 2025, with an ultimate completion date of June 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal vaccine critical to military and federal healthcare systems, supporting...
- The Defense Logistics Agency awarded a delivery order valued at $8,274.97 to AmerisourceBergen Drug Corp for PREVNAR 20 Syringe 0.5ML, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease, supporting the federal government's medical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,217.54 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5 mL) on October 22, 2025, with completion targeted for October 23, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease across multiple age groups,...
- The Defense Logistics Agency awarded a delivery order valued at $8,453.56 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5ML) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used for immunization against pneumococcal...
- The Defense Logistics Agency awarded a $12,261.63 firm fixed price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a non-set-aside contract, competitively awarded to the pharmaceutical distributor's Corporate Office division located in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease in eligible populations, representing...
- The Defense Logistics Agency awarded a delivery order valued at $13,220.22 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) on July 11, 2025, with an ultimate completion date of July 14, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal vaccine used to prevent pneumococcal disease across multiple age groups...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB26FY2L7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $120,771.10 to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5ml syringes. This firm fixed-price, non-set-aside delivery order is scheduled for completion by November 10, 2025, and will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. PREVNAR 20 is a pneumococcal conjugate vaccine used to prevent pneumococcal disease and represents a critical pharmaceutical commodity for military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp supplies a broad portfolio of medications, vaccines, and medical supplies to support Defense Health Agency and other federal healthcare systems worldwide. The company's competitive award history and established IDC demonstrate its capability to meet federal medical procurement requirements for essential vaccine products and related healthcare commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $120.8k | 11/7/25 |